SMT201500124B - Composizioni di bifosfonati e metodi per il trattamento dell'insufficienza cardiaco - Google Patents

Composizioni di bifosfonati e metodi per il trattamento dell'insufficienza cardiaco

Info

Publication number
SMT201500124B
SMT201500124B SM201500124T SM201500124T SMT201500124B SM T201500124 B SMT201500124 B SM T201500124B SM 201500124 T SM201500124 T SM 201500124T SM 201500124 T SM201500124 T SM 201500124T SM T201500124 B SMT201500124 B SM T201500124B
Authority
SM
San Marino
Prior art keywords
bisphosphonates
compositions
treatment
methods
heart failure
Prior art date
Application number
SM201500124T
Other languages
English (en)
Italian (it)
Inventor
Kenneth W Lyles
Cathleen S Colon-Emeric
Christopher O'connor
Richard S Stack
Niaye Colleen Stack-D
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of SMT201500124B publication Critical patent/SMT201500124B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SM201500124T 2009-09-01 2015-05-26 Composizioni di bifosfonati e metodi per il trattamento dell'insufficienza cardiaco SMT201500124B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23879709P 2009-09-01 2009-09-01
PCT/US2010/047417 WO2011028737A2 (en) 2009-09-01 2010-09-01 Bisphosphonate compositions and methods for treating heart failure

Publications (1)

Publication Number Publication Date
SMT201500124B true SMT201500124B (it) 2015-07-09

Family

ID=43649931

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500124T SMT201500124B (it) 2009-09-01 2015-05-26 Composizioni di bifosfonati e metodi per il trattamento dell'insufficienza cardiaco

Country Status (12)

Country Link
US (2) US9867838B2 (xx)
EP (1) EP2473172B1 (xx)
CN (2) CN102639137A (xx)
DK (1) DK2473172T3 (xx)
ES (1) ES2537216T3 (xx)
HR (1) HRP20150496T1 (xx)
HU (1) HUE025737T2 (xx)
PL (1) PL2473172T3 (xx)
PT (1) PT2473172E (xx)
SI (1) SI2473172T1 (xx)
SM (1) SMT201500124B (xx)
WO (1) WO2011028737A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US9949992B2 (en) 2011-11-16 2018-04-24 Duke University Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
WO2021207047A1 (en) * 2020-04-06 2021-10-14 Duke University Compositions and methods for the treatment of infection-induced cardiomyopathy

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE3428524A1 (de) 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4639338A (en) 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
DE3770982D1 (de) 1986-04-24 1991-08-01 Fujisawa Pharmaceutical Co Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5057505A (en) 1986-11-21 1991-10-15 Ciba-Geigy Corporation Substituted aminomethanediphosphonic acids and use in medicaments
ATE72816T1 (de) 1986-11-21 1992-03-15 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
GB8808138D0 (en) 1988-04-07 1988-05-11 Leo Pharm Prod Ltd Chemical compounds
EP0544812B1 (en) 1990-08-21 1995-04-05 The Upjohn Company Bisphosphonic acid derivatives as anti-arthritic agents
US5157027A (en) 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
KR100244603B1 (ko) 1991-05-28 2000-03-02 데이비드 엠 모이어 칼슘,미량무기물,비타민 디 또는 디포스포네이트를 포함하는 골 강화용 식품 보충제
EP0600834A1 (en) 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US6117856A (en) 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
DE19738005A1 (de) * 1997-08-30 1999-03-04 Bayer Ag Verwendung von substituierten 1,1-Bisphosphonaten
CA2317459A1 (en) 1998-01-29 1999-08-05 Merck & Co., Inc. Methods of identifying modulators of kinases responsive to stress
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
JP2003519183A (ja) 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
WO2001064207A2 (en) * 2000-03-01 2001-09-07 University Of South Florida Methods of modulating cell-adhesion mediated drug resistance
GB0012209D0 (en) 2000-05-19 2000-07-12 Novartis Ag Organic compounds
US8052987B2 (en) 2000-06-20 2011-11-08 Novartis Pharmaceuticals Corporation Method of administering bisphosphonates
EP1418897A2 (en) * 2001-05-02 2004-05-19 Novartis AG Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
US20030064965A1 (en) 2001-10-02 2003-04-03 Jacob Richter Method of delivering drugs to a tissue using drug-coated medical devices
JP2005531532A (ja) 2002-04-05 2005-10-20 メルク　エンド　カムパニー　インコーポレーテッド アレンドロナートおよびビタミンｄ製剤を用いる骨吸収阻害法
EP1506208A4 (en) 2002-05-11 2006-05-24 Ilex Products Inc USE OF 1,1 AND 1,2-DIPHOSPHONATES AS MODULATORS OF APOLIPOPROTEIN E
US20050026871A1 (en) 2002-07-17 2005-02-03 Moshe Flashner-Barak Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
JP2006500402A (ja) * 2002-09-16 2006-01-05 ノバルティス　アクチエンゲゼルシャフト 股関節骨折後における二次骨折の予防または低減化方法
JP2006504749A (ja) 2002-10-15 2006-02-09 ノバルティス アクチエンゲゼルシャフト アテローム性動脈硬化症の処置のためのビスホスホネートおよびそれらを含むデバイス
ES2333220T3 (es) * 2002-12-30 2010-02-18 Celgene Corporation Compuestos 1,3-dihidro-isoindolilo sustituidos con fluoroalcoxi y sus usos farmaceuticos.
US10517883B2 (en) * 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
US20060051407A1 (en) 2003-06-27 2006-03-09 Yoram Richter Method of treating ischemia-reperfusion injury
JP4621202B2 (ja) 2003-06-27 2011-01-26 バイオレスト リミテッド 急性冠症候群を治療する方法
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
CA2539359A1 (en) 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate
GB0327742D0 (en) * 2003-11-28 2003-12-31 Isis Innovation Novel uses of known drugs
US20060069068A1 (en) 2004-07-15 2006-03-30 Nanobac Pharmaceuticals, Inc. Methods and compositions for the treatment of diseases characterized by pathological calcification
AU2005275193A1 (en) 2004-07-15 2006-02-23 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
JP5450052B2 (ja) * 2006-04-07 2014-03-26 メリオン リサーチ Ｉｉｉ リミテッド 強化剤を含む固体経口投与剤形
EP1925621A1 (en) * 2006-11-27 2008-05-28 Novartis AG Crystalline forms of zoledronic acid
US20080146489A1 (en) 2006-12-15 2008-06-19 Pacetti Stephen D Regional delivery of therapeutic agents for the treatment of vascular diseases
EP2136814A4 (en) 2007-03-21 2012-05-30 Univ Duke MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
CN104188971B (zh) * 2007-12-21 2017-05-03 配体药物公司 选择性雄激素受体调节剂(sarm)及其应用
CN101259133A (zh) * 2008-03-28 2008-09-10 王洪 唑来磷酸用于制备预防及治疗骨质疏松症的药物
US20110112053A1 (en) 2008-04-16 2011-05-12 University Of Utah Research Foundation Pharmacological targeting of vascular malformations

Also Published As

Publication number Publication date
EP2473172B1 (en) 2015-04-08
EP2473172A4 (en) 2013-01-16
US9867838B2 (en) 2018-01-16
CN105920023A (zh) 2016-09-07
HRP20150496T1 (hr) 2015-08-14
CN102639137A (zh) 2012-08-15
HUE025737T2 (en) 2016-05-30
PL2473172T3 (pl) 2015-08-31
WO2011028737A8 (en) 2012-05-18
PT2473172E (pt) 2015-06-25
ES2537216T3 (es) 2015-06-03
US20120208786A1 (en) 2012-08-16
DK2473172T3 (en) 2015-06-15
SI2473172T1 (sl) 2015-07-31
WO2011028737A3 (en) 2011-07-14
WO2011028737A2 (en) 2011-03-10
US20180125869A1 (en) 2018-05-10
EP2473172A2 (en) 2012-07-11

Similar Documents

Publication Publication Date Title
IL272817A (en) New preparations and methods for the treatment of vaccine-related diseases
SMT201500124B (it) Composizioni di bifosfonati e metodi per il trattamento dell'insufficienza cardiaco
EP2129683A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS
HK1163500A1 (en) Pharmaceutical composition for the treatment of heart diseases
SMT201700014B (it) Agenti terapeutici per la riduzione dei livelli dell'ormone paratiroideo
EP2440209A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
HK1147767A1 (en) Compositions and methods for the therapy and diagnosis of influenza
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
EP2279009A4 (en) METHOD AND COMPOSITIONS FOR TREATING OR PREVENTING PATHOLOGICAL CARDIAL REMODELING AND HEART FAILURE
SMT201400160B (it) Nuove composizioni per il trattamento di cmt e malattie correlate
ZA201101278B (en) Compounds,compositions and methods for the treatment of b-amyloid diseases and synucleinopathies
BRPI1013245A2 (pt) "composto para o tratamento de distúrbios metabólicos"
SMT201400165B (it) Composizioni e metodi per il trattamento di sclerosi multipla
SMT201600041B (it) Agenti terapeutici 713
IT1403587B1 (it) Composizione per il trattamento di disordini metabolici
BR112013004683A2 (pt) "conjunto de cateter para tratamento de nervo"
ITRM20080546A1 (it) Sedia ginnica per la stimolazione dell'apparato muscolo-scheletrico
PL2323625T3 (pl) Nowa kompozycja do leczenia pigmentacji wybroczynowych
SMT201600224B (it) Trattamento dell'osteoporosi
SMT201300156B (it) Composti solfonammidici per il trattamento di disturbi respiratori
BR112013007039A2 (pt) "composição de tratamento pessoal"
PL2307380T3 (pl) Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego
GB0806047D0 (en) Treatment of heart failure
IT1401083B1 (it) Composizione per il trattamento e la prevenzione dell'herpes simplex labiale.